Teleflex Inc. Reports Q2 2026 Results; Furnishes Press Release & Slides

What Happened

• Teleflex Incorporated filed a Form 8‑K on August 6, 2026 (Item 2.02) announcing its financial results for the quarter ended June 30, 2026. The company furnished a press release as Exhibit 99.1 and an earnings conference call slide presentation as Exhibit 99.2 (Item 7.01).
• The press release includes both GAAP results and several non‑GAAP measures the company uses to assess performance, including pro forma adjusted revenue, pro forma adjusted constant‑currency revenue growth, and adjusted diluted earnings per share.

Key Details

• Filing date: August 6, 2026; Quarter reported: quarter ended June 30, 2026.
• Exhibits furnished: Press Release (Exhibit 99.1) and Earnings Slide Presentation (Exhibit 99.2).
• Non‑GAAP measures explained: adjustments include (as applicable) exclusion of: discontinued products from 2025 strategic realignment; pro forma effect of the Vascular Intervention acquisition from BIOTRONIK as if closed Jan 1, 2025; certain prior‑year Italian reserve adjustments; and exclusion of items such as restructuring, impairments, acquisition/integration/divestiture costs, separation costs tied to the company’s Strategic Divestitures (Acute Care, Interventional Urology, OEM), EU Medical Device Regulation registration costs, intangible amortization, ERP/IT transition costs, and tax adjustments.
• Management states these non‑GAAP measures are used for internal decision‑making and peer comparisons but cautions they are supplemental to GAAP and may not be comparable to similarly titled measures used by other companies.

Why It Matters

• Investors get the company’s latest quarterly results and the firm’s view of underlying performance through adjusted/non‑GAAP metrics; those metrics reflect the impact of the BIOTRONIK vascular business acquisition (on a pro forma basis) and exclusion of several one‑time or structural items.
• The filing highlights ongoing strategic changes (divestiture activity and related separation costs) and other non‑recurring items that could affect near‑term reported earnings and comparability with prior periods.
• Retail investors should review the furnished press release and slide deck for the actual GAAP numbers, reconciliations to the non‑GAAP measures, and management commentary before making investment decisions.